Prediction of disease-free survival using relative change in FDG-uptake early during neoadjuvant chemoradiotherapy for potentially curable esophageal cancer: A prospective cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prediction of disease-free survival using relative change in FDG-uptake early during neoadjuvant chemoradiotherapy for potentially curable esophageal cancer: A prospective cohort study

Published:2016-03 Issue: Volume: Page:n/a-n/a
ISSN:1120-8694
Container-title:Diseases of the Esophagus
language:en
Short-container-title:Diseases of the Esophagus

Author:

Hagen P. V.¹,Heijl M. V.²³,Henegouwen M. I. V. B.²,Boellaard R.⁴,Bossuyt P. M. M.⁵,Kate F. J. W. T.⁶⁷,Dekken H. V.⁷⁸,Hoekstra O. S.⁴,Sloof G. W.⁹¹⁰,Lanschot J. J. B. V.¹²

Affiliation:

1. Department of Surgery; Erasmus Medical Center; Rotterdam

2. Department of Surgery; Academic Medical Center; Amsterdam

3. Department of Surgery; University Medical Center Utrecht; Utrecht The Netherlands

4. Department of Nuclear Medicine and PET research; VU Medical Center; Amsterdam

5. Department of Clinical Epidemiology, Biostatistics and Bioinformatics; Academic Medical Center; Amsterdam

6. Department of Pathology; Academic Medical Center; Amsterdam

7. Department of Pathology; Erasmus Medical Center; Rotterdam

8. Department of Pathology; Sint Lucas Andreas Hospital; Amsterdam

9. Department of Nuclear Medicine; Academic Medical Center; Amsterdam

10. Department of Nuclear Medicine; Groene Hart Hospital; Gouda

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/dote/article-pdf/30/2/1/17727596/dote12479.pdf

Reference41 articles.

1. F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world;Kamangar;J Clin Oncol,2006

2. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival;Berger;J Clin Oncol,2005

3. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial;Omloo;Ann Surg,2007

4. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial;Shapiro;Lancet Oncol,2015

5. Preoperative chemoradiotherapy for esophageal or junctional cancer;Hagen;N Engl J Med,2012

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thromboprophylaxis in oesophageal cancer patients—a study protocol for a randomised, controlled trial (TOP-RCT);Trials;2024-09-06

2. Hypofractionated radiotherapy plus PD-1 antibody and SOX chemotherapy as second-line therapy in metastatic pancreatic cancer: a single-arm, phase II clinical trial;Cancer Immunology, Immunotherapy;2024-08-06

3. Combined Chemotherapy and Immunotherapy Induction for Screening of Patients with Cervical Esophageal Carcinoma for Subsequent Local Treatment: A New Treatment Paradigm;Annals of Surgical Oncology;2024-07-26

4. Arachidonic acid metabolism as a novel pathogenic factor in gastrointestinal cancers;Molecular and Cellular Biochemistry;2024-07-04

5. The State of Synthetic Cannabinoid Medications for the Treatment of Pain;CNS Drugs;2024-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3